Journal
PEDIATRICS
Volume 133, Issue 3, Pages 563-567Publisher
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2013-4060
Keywords
off-label drug use; pharmaceuticals; pediatrics; infants; children; adolescents; prescribing
Categories
Ask authors/readers for more resources
The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an overwhelming number of drugs still have no information in the labeling for use in pediatrics. The purpose of off-label use is to benefit the individual patient. Practitioners use their professional judgment to determine these uses. As such, the term off-label does not imply an improper, illegal, contraindicated, or investigational use. Therapeutic decision-making must always rely on the best available evidence and the importance of the benefit for the individual patient.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available